Shares of Eli Lilly are up 150% over the last 2 years as investors are bullish about the new weight loss drugs. Is it too hot to handle?
(1:00) - Breaking Down Eli Lilly's Performance: Is It Still Worth Buy Right Now?
(11:30) - Taking A Look At The Competition: Is Their Valuation More Attractive?
(17:20) - Episode Roundup: LLY, NVO
